Back to search
Heart Septal Defect
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Septal Defect trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Septal Defect trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The goal of this observational study is to develop and validate a multimodal artificial intelligence prediction model for treatment-related complications in chi…
This study will assess the safety and effectiveness of GORE® CARDIOFORM Septal Occluder in a post approval setting and evaluate the quality of operator educatio…
The Occlutech® mVSD is indicated for percutaneous occlusion of hemodynamically or clinically significant muscular ventricular septal defects. The objectives of…
The goal of this clinical trial is to test a new heart device called P3 Occluder System in patients who have a small opening between the upper chambers of the h…
This study will demonstrate the safety and effectiveness of the Edwards Lifesciences SAPIEN 3/SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve (THV) Systems in…
Patent foramen ovale (PFO) is a congenital interatrial communication present in about one quarter of the general population and is recognized as a major cause o…
The goal of this clinical trial was to compare two settings on a breathing machine used during heart surgery in children. The children in this study were born…
The objective of this study is to establish a more comprehensive model for evaluating the condition of children with ventricular septal defect and predicting th…